CIK 0001828673
- Non-accelerated filer
- Smaller reporting company
- Emerging growth company
HCW Biologics Inc.
Sign in to watch- Ticker
- HCWB
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 825024477
- Phone
- +1 954-842-2024
- Business address
- 2929 N COMMERCE PKWY, MIRAMAR, FL, 33025
- 4 Derivatives Options or other derivatives
- 4 Open-market buy SVP of Business Development bought 10,000 shares at $2.16 ($21,574)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at $2.06 ($41,286)
- 4 Open-market buy Chief Financial Officer bought 24,696 shares at an average $2.07 ($51,020)
- 4 Open-market buy Chief Financial Officer bought 39,062 shares at an average $1.74 ($68,123)
- 4 Open-market buy Chief Executive Officer bought 1,600 shares at an average $1.58 ($2,522)
- 4 Open-market buy Chief Executive Officer bought 5,000 shares at an average $1.55 ($7,750)
- 4 Open-market buy Director bought 1,350 shares at an average $1.51 ($2,043)
- 4 Open-market buy Chief Financial Officer bought 40,000 shares at an average $1.64 ($65,544)
- 4 Open-market buy Chief Financial Officer bought 58,486 shares at an average $1.56 ($91,082)
- 4 Option exercise Chief Financial Officer acquired 33,750 shares (option exercise)
- 4 Open-market buy Chief Financial Officer bought 15,000 shares at $2.58 ($38,651)
- 4 Open-market buy Chief Financial Officer bought 30,000 shares at an average $2.61 ($78,414)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $2.69 ($26,880)
- 4 Open-market buy Chief Executive Officer bought 10,000 shares at an average $2.57 ($25,680)
- 4 Open-market buy Chief Financial Officer bought 17,200 shares at an average $2.55 ($43,913)
- 4 Open-market buy Chief Financial Officer bought 20,000 shares at an average $2.55 ($51,020)
- 4 Open-market buy Chief Financial Officer bought 90,300 shares at an average $2.54 ($229,747)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
Page 3 of 6 · 109 filings